Table 1.
Considerations when modeling idiopathic PD in rodents.
| Feature | AAV-overexpression models | α-syn PFF model |
|---|---|---|
| Ability to examine impact of α-synuclein inclusions distinct from degeneration | Difficult | Straightforward |
| Simultaneous α-syn overexpression and aggregation progresses rapidly to degeneration over the course of weeks | Distinct interval of inclusion formation followed by degeneration over a protracted time course | |
| Injection artifact | Confound | Less of a factor |
| Direct injections into the SN produce marked neuroinflammatory response that can make interpretation difficult | Direct injections into the striatum have less of an impact within the SN | |
| α-synuclein levels | Not analogous to idiopathic PD | Normal endogenous α-syn levels |
| Continuous supraphysiological α-syn levels produced by forced overexpression are not analogous to idiopathic PD | Pathophysiology results from templating of normal levels of α-syn | |
| Extranigral α-synuclein pathology | Not present | α-syn pathology in multiple regions |
| Pathology limited to the nigrostriatal system | Allows for the examination of events outside of nigrostriatal system |
Abbreviations: AAV, adeno-associated virus; α-syn, alpha-synuclein; PD, Parkinson’s disease; PFFs, alpha-synuclein preformed fibrils; SN, substantia nigra.